LEUKOCYTE ANTIGEN CD37

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 20:32:22 GMT 2025` Edited by `admin` on `Tue Apr 01 20:32:22 GMT 2025`
Protein Type	RECEPTOR
Protein Sub Type
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	VTD13G7FDK
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CD37

Preferred Name

English

LEUKOCYTE ANTIGEN CD37

Common Name

English

TSPAN-26

Common Name

English

TETRASPANIN-26

Common Name

English

TSPAN26

Common Name

English

Code System Code Type Description

UNIPROT

P11049

Created by admin on Tue Apr 01 20:32:22 GMT 2025 , Edited by admin on Tue Apr 01 20:32:22 GMT 2025

PRIMARY

FDA UNII

VTD13G7FDK

Created by admin on Tue Apr 01 20:32:22 GMT 2025 , Edited by admin on Tue Apr 01 20:32:22 GMT 2025

PRIMARY

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_170
N	1_183
N	1_188

Related Record Type Details


					LB090AB8DB

BI-836826

INHIBITOR -> TARGET


					ITW0M69HMB

NARATUXIMAB

INHIBITOR -> TARGET

Amount:


					WE1X5A83B9

NARATUXIMAB EMTANSINE

CONJUGATED TOXIN->TARGET

Amount:


					CPW7BR9UY7

TETULOMAB TETRAXETAN LU-177

INHIBITOR -> TARGET

Amount:


					054ZP16K2Q

LUTETIUM (LU177) LILOTOMAB SATETRAXETAN

INHIBITOR -> TARGET

Amount:


					4O7JS64H45

IVICENTAMAB

LIGAND->TARGET

Comments:

A bispecific CD37 antibody with the E430G hexamerization-enhancing mutation targeting two non-overlapping epitopes on CD37 (biparatopic), demonstrated potent and superior CDC activity compared to other CD37 antibody variants

Amount:


					58I6YNR7BV

LILOTOMAB

INHIBITOR -> TARGET


					2MZ3L2664T

OTLERTUZUMAB

INHIBITOR -> TARGET

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL